Atea Pharmaceuticals (AVIR) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.75
-0.62
-0.5
-0.37

Details

Expected EPS
-0.4267
Actual EPS
-0.37
Surprise EPS
0.06
Surprise Percent
+13.29%

Description

⁨Atea Pharmaceuticals⁩ (⁦AVIR⁩) has reported earnings of ⁦-0.37⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts